AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENDRA Life Sciences Inc. Director's Dealing 2022

Jan 4, 2022

Director's Dealing

Opens in your device viewer

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2022-01-03

Reporting Person: DIGIANDOMENICO ANTHONY (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-03	Stock Options	$0.74	A	12000	Acquired	2032-01-03	Common Stock (12000)	Direct

F1: Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy.